Msn Pharmachem Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is ARIPIPRAZOLE USP [ROUTE CODE - "AL1"], with a corresponding US DMF Number 24090.
Remarkably, this DMF maintains an Active status since its submission on August 23, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of November 23, 2012, and payment made on November 14, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II